$BLBD Cashflow Statement | Understand Stock

$BLBD

$56.82 -$1.22 (2.1%) Close

$BLBD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 27, 2025	FY2024 12 months to Sep 28, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Oct 1, 2022	FY2021 12 months to Oct 2, 2021
Cash flows from operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense
Non-cash interest expense
Share-based compensation expense
Equity in net (income) loss of non-consolidated affiliate(s)
Equity in net income of non-consolidated affiliate(s)
Dividend from equity investment in affiliate(s) (Note 17)
Impairment of equity investment in affiliate(s) (Note 17)
Lower of cost or net realizable value loss
Loss on disposal of fixed assets
Deferred income tax expense (benefit)
Amortization of deferred actuarial pension losses
Loss on debt refinancing or modification
Foreign currency hedges
Changes in assets and liabilities:
Accounts receivable
Inventories
Other assets
Accounts payable
Accrued expenses, pension and other liabilities
Dividend from equity investment in non-consolidated affiliate
Total adjustments

Total cash provided by operating activities
Cash flows from investing activities
Cash paid for fixed assets
Proceeds from sale of fixed assets
Equity investment in affiliate(s) (Note 17)
Total cash used in investing activities
Cash flows from financing activities
Net borrowings under the revolving credit facility
Borrowings under the term loan
Proceeds from lines of credit
Revolving credit facility repayments
Term loan borrowings - new credit agreement (Note 8)
Term loan repayments (Note 8)
Principal payments on finance leases
Cash paid for debt costs (Note 8)
Net cash received (paid) for exercises and employee taxes on vested restricted shares and stock option exercises
Sale of common stock (Note 13)
Cash paid for common stock issuance costs (Note 13)
Proceeds from exercises of warrants
Repurchase of common stock in connection with repurchase program(s) (Note 13)
Equity investment in affiliate(s) (Note 17)
Repurchase of common stock in connection with stock award exercises
Cash received from stock option exercises
Cashless exercise of warrants
Total cash used in financing activities

Change in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental disclosures of cash flow information
Interest paid
Interest received
Income tax paid (received), net of tax refunds
Non-cash investing and financing activities:
Changes in accounts payable for capital additions to property, plant and equipment
Cashless exercise of stock options
Right-of-use assets obtained in exchange for operating lease obligations
Right-of-use assets obtained in exchange for finance lease obligations
Conversion of preferred stock into common stock
Finance lease right-of-use assets removed due to non-renewal of lease
Finance lease obligations removed due to non-renewal of lease
Warrants issued for equity investment in affiliate (Note 17)

Comments